MVX0002 Phase I

Group B Streptococcus Vaccine in Healthy Females

Description:

Safety and dose-finding Phase I study testing dual-component GBS-NN & GBS-NN2 vaccine composition covering 99.3% of clinical GBS isolates.

Status:

Study is completed

Countries:

UK

Links

Clinicaltrials.gov